Chetan Parekh

Spearheaded the Product pipeline development strategy & execution. Ideas to life.

• Peak sales pipeline value of $200 M
• First to market generics, Life cycle management and NCE lineup to augment growth.
• Led cross-functional teams in the development of innovative solutions to complex problems in sourcing, supplies, and costs.
• Managed crisis situations to minimize the impact on development, operations, and reputation.
• Value creation through sourcing and partnerships with supplier to improve gross margin.

• Business development,Sourcing,Licensing to drive the NPI growth pipeline of $100 MM
• Robust pipeline validated and supported by outside-in & inside-out sourcing.
• CFT collaboration to bring ideas to life at the Innovation board & drive to win.
• FTM generic launches- A first
• Gross margin improvement .
• Large licensing deals
• Biosimilar strategy and implementation.

• Reporting to CEO & management team member based out of India.
• Multiple large licence deals worth $50M in sales and supply chain resilience initiatives to speed to market.
• Geo-expansion of product from India to 14 latam markets.
• Pipeline value of $75M
• Biosimilar strategy & implementation with projected $50M sales.
• Due diligence in acquisitions/audits
• Gross margin improvements.

• Overall Strategy & implementation to grow by 20% yoy..
• Strategized and implemented plans to transform and revitalize operations, capitalizing on emerging trends.
• Established and oversaw strategic business actions and streamlined operations.
• Improved profitability by accurately maintaining P&L to meet prime fiscal responsibility.
• Implemented strategic offerings to enhance company's suite of products and services.
• Consultation to large manufacturers to grow together.

• Reporting to CEO- Mr Mehul Parekh.
• BD including inlicensing of molecules.
• Strategized the manufacturing & marketing to drive growth by 200%.
• Profit improvement by 30%.
• Penetration in 20 Global markets.
• Trading with 25% gross margin without using company funds.
• 50% image improvement on account of improved efficiencies.

• Reporting to the CEO.
• Strategy and implementation for API, FDF, OTC, Veterinary, and Herbal products in over 100 international markets. markets.
• Penetration in 40-plus markets and leader in key 25 markets, spanning a business of $100 million.
• Single-point empowered decision on API, FDF, and technology for any market to accelerate growth.
• Market- and customer-led product development and offerings to drive growth.
• Development sourcing should have better market speed and penetration.
• Business verticals of OTC, Herbal, Veterinary products, as well as trading activities.
• The joint venture in the UAE became profitable in two years, with a rich pipeline of $20 million.
• Successful audits by different MOHs.
• Customer and brand of choice in multiple markets.
• Product mix of over 100 products, including oncology.
• In-person launches in key 15 markets.

Reporting to CEO

• Strategy of Zee Herbal Balm for USA worth $5M
• Product differentiation & sourcing strategies

• Topper in Sales Training among 50 selected All India representatives.
• Independent charge of four districts, and launch of the 'Pulsar' division.
• Penetration and growth of 50% in three months.
• Excellent interpersonal skill development.
• On-ground learning and implementation.
• Insights into implementation.